GRCE

NASDAQStock

Grace Therapeutics, Inc.

$4.15+0.09 (+2.22%)

52-Week Range

$1.80

$4.29

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

0.76

Volume

323.6K

Avg Volume

395.9K

Performance

+15.01%

+25.31%

+32.25%

YTD

+10.93%

+86.24%

+26.48%

Price Chart

ETF Exposure

GRCE is held by 6 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	19	$96	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	703	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	3	$16	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	400,350	$1.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,105	$10K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	181	$892	$1.29B	0.17%

About GRCE ETF Exposure

Grace Therapeutics, Inc. (GRCE) is held by 6 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $4.15. Investors can gain exposure to GRCE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold GRCE, sorted by portfolio weight.